Recent News

• 08.29.2025 - Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera
• 07.30.2025 - NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy
• 07.29.2025 - NeoGenomics Reports Second Quarter 2025 Results
• 07.01.2025 - NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
• 06.30.2025 - NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
• 06.24.2025 - NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

Recent Filings

• 08.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.08.2025 - 8-K Current report
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 07.29.2025 - 8-K Current report
• 07.29.2025 - EX-99.1 EX-99.1
• 07.29.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.17.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors